News Archive

PrEP Works Despite Missed Doses, Although Daily Use Is Advised

PrEP protects with less than 100% adherence, according to findings presented at AIDS 2014. What does this mean for “real-world” PrEP use?

Just How Risky Is It? Studies Shed Light on HIV Risk and Prevention

Three studies estimate HIV risk by sex act and HIV prevention approach. How applicable are their findings to the “real world”?

Fact Sheet: PrEP and PEP

Curious about PrEP and PEP—and the difference between them? Start here for key terms and concepts to help you understand these two ways to preventing HIV infection.

CROI 2013: iPrEx Update—A Q&A with Dr. Robert Grant

Robert Grant, MD, explains findings from the seminal iPrEx trial which showed that Truvada PrEP reduced risk of HIV transmission by 99%.

The “Berlin Patient”: Sorting Out the Science

Talk and questions abound about traces of HIV found in the "Berlin Patient"—the first person believed cured of the virus. What does it all mean for the prospect of an HIV cure?

Filter by

PrEP Works Despite Missed Doses, Although Daily Use Is Advised

Just How Risky Is It? Studies Shed Light on HIV Risk and Prevention

Fact Sheet: PrEP and PEP

CROI 2013: iPrEx Update—A Q&A with Dr. Robert Grant

The “Berlin Patient”: Sorting Out the Science

A Guide to Clinical Trials: Understanding Clinical Studies